Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 17(1): e0262416, 2022.
Article in English | MEDLINE | ID: mdl-34995318

ABSTRACT

BACKGROUND: Mucosal infiltration by certain bacterial species may contribute to the development and progression of colorectal cancer (CRC). There is considerable variation in reported detection rates in human CRC samples and the extent to which bacterial infiltration varies across regions of the primary tumour is unknown. This study aimed to determine if there is an optimal site for bacterial detection within CRC tumours. METHODS: Presence of target bacterial species was assessed by quantitative real-time PCR (qPCR) in 42 human CRC tumours. Abundance in primary tumour regions, normal epithelium and at metastatic sites was investigated in an expanded cohort of 51 patients. Species presence/absence was confirmed by diversity profiling in five patients. Correlation with total bacterial load and clinicopathological features was assessed. RESULTS: Fusobacterium nucleatum and Bacteroides fragilis were detected in tumours from 43% and 24% of patients, respectively (17% positive for both species). The optimal detection site was the tumour luminal surface (TLS). Patients testing positive at the TLS frequently tested negative at other sites, including central tumour and invasive margin. F. nucleatum was detected at a higher frequency in tumour versus normal epithelium (p < 0.01) and was associated with more advanced disease (p = 0.01). Detection of both species correlated with total bacterial load. However, corroboration of qPCR results via diversity profiling suggests detection of these species may indicate a specific microbial signature. CONCLUSIONS: This study supports a role for F. nucleatum in CRC development. Presence of F. nucleatum and B. fragilis varies across primary tumour regions, with the TLS representing the optimal site for bacterial detection.


Subject(s)
Bacteroides Infections/complications , Bacteroides fragilis/isolation & purification , Colorectal Neoplasms/microbiology , Fusobacterium Infections/complications , Fusobacterium nucleatum/isolation & purification , Adult , Aged , Aged, 80 and over , Bacterial Load , Bacteroides Infections/diagnosis , Colorectal Neoplasms/etiology , Female , Fusobacterium Infections/diagnosis , Humans , Male , Middle Aged
2.
Prostate ; 68(14): 1487-91, 2008 Oct 01.
Article in English | MEDLINE | ID: mdl-18651564

ABSTRACT

BACKGROUND: Propionibacterium sp. and Staphylococcus spp. are the most frequent bacteria cultured from prostatectomy specimens but are seldom detected by universal eubacterial PCR. MATERIALS AND METHODS: We obtained from GenBank representative 16S rRNA gene sequences from Propionibacterium sp., Staphylococcus spp. and from 34 bacterial genera that were recently detected in prostate tissues using universal eubacterial PCR. We compared these 16S rDNA sequences with the universal eubacterial 16S PCR primer sets chosen for detection of bacterial DNA in prostate tissues. RESULTS: We show that failure to detect DNA from Propionibacterium sp. and Staphylococcus spp. in prostate tissues is strongly associated with the presence of mismatches near the 3' termini of the 16S rDNA primer sets used. CONCLUSIONS: The choice of 16S PCR primers may play an important role in determining the spectrum of bacterial genera detected in prostate tissue by universal eubacterial PCR.


Subject(s)
DNA Primers/genetics , Polymerase Chain Reaction/methods , Propionibacterium acnes/isolation & purification , Prostate/microbiology , RNA, Ribosomal, 16S/genetics , Staphylococcus/isolation & purification , DNA Primers/chemistry , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Humans , Male , Propionibacterium acnes/genetics , RNA, Ribosomal, 16S/chemistry , Sequence Alignment , Sequence Analysis, DNA , Staphylococcus/genetics
3.
J Urol ; 179(5): 1762-7; discussion 1767, 2008 May.
Article in English | MEDLINE | ID: mdl-18343454

ABSTRACT

PURPOSE: The central zone of the prostate gland is a region rarely associated with carcinoma. To our knowledge central zone tumors have not previously been compared to carcinoma originating in the peripheral or transition zone of the prostate gland. MATERIALS AND METHODS: All 2,010 radical prostatectomy cases seen at our institution from October 1998 to December 2006 were reviewed to identify tumor zonal origin. Central zone carcinoma was characterized and compared with tumors of other zones. RESULTS: Zonal origin was determined in a total of 2,494 tumors in 1,703 cases. Of the tumors 63 (2.5%) were of central zone origin with 59 of the 63 representing the index or main tumor. Comparative analysis of a defined subset of 726 cases showed that central zone cancers were significantly more aggressive than peripheral or transition zone cancers with a far greater risk of extracapsular extension, seminal vesicle invasion and positive surgical margins. Escape from the gland was often via the ejaculatory ducts and seminal vesicles. Kaplan-Meier analysis confirmed that the probability of post-prostatectomy biochemical failure was double that of tumors of the other zones with a far more rapid rate of failure. Multivariate Cox regression analysis identified Gleason grade, positive margins, extracapsular extension, tumor volume and preoperative serum prostate specific antigen as the major contributors to this poor prognosis, rather than specific zonal origin. CONCLUSIONS: To our knowledge this study provides the first characterization and comparative analysis of central zone carcinoma, identifying these tumors as a rare but highly aggressive form of prostate carcinoma with a distinct route of spread from the gland that contrasts with tumors of other zones. Preoperative identification is currently hampered by the avoidance of biopsy targeting the central zone. However, if recognized preoperatively, aggressive intervention may possibly improve the currently bleak outlook.


Subject(s)
Carcinoma/pathology , Prostate/pathology , Prostatic Neoplasms/pathology , Aged , Carcinoma/diagnosis , Carcinoma/surgery , Humans , Male , Middle Aged , Prognosis , Prostate-Specific Antigen/blood , Prostatectomy , Prostatic Intraepithelial Neoplasia/pathology , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/surgery
4.
BJU Int ; 101(4): 429-35, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17850358

ABSTRACT

OBJECTIVE: To investigate whether the serum titres of Propionibacterium acnes antibodies in patients undergoing prostate biopsy are associated with prostate cancer or markers of prostate disease, including serum prostate-specific antigen (PSA) levels. PATIENTS AND METHODS: The cell wall-associated proteins from P. acnes types IA, IB and II were extracted and characterized by Western blotting and immunoblotting. We developed an enzyme-linked immunosorbent assay (ELISA) based on extracted proteins to determine the anti-P. acnes antibody titres in the sera of 68 patients undergoing prostate biopsy. Correlations between these titres and multiple markers of prostate disease were investigated. RESULTS: In patients with biopsies negative for cancer, a high anti-P. acnes antibody titre was associated with high serum PSA levels (>or=10.0 ng/mL, P = 0.04), and multiple linear regression analysis identified antibody titre as the predominant independent predictor of serum PSA level (P = 0.03). The titre was positively correlated with patient age, prostate volume and aggressive inflammation, suggesting an involvement with benign prostatic hyperplasia (BPH). However in patients with histologically detected cancer, the volume of cancer in the biopsy cores was the predominant independent predictor of serum PSA (P = 0.01). CONCLUSIONS: These results support our hypothesis that P. acnes might be involved in the development of inflammation-related prostate diseases, in particular with BPH. Our ELISA might be valuable for identifying P. acnes infection of the prostate gland in patients with elevated serum PSA levels but a negative biopsy, and might identify men at risk of developing clinical BPH. However, an investigation with more patients is needed to confirm these preliminary findings.


Subject(s)
Antibodies, Bacterial/immunology , Gram-Positive Bacterial Infections/immunology , Propionibacterium acnes/immunology , Prostate-Specific Antigen/blood , Prostatic Hyperplasia/immunology , Prostatic Neoplasms/immunology , Aged , Aged, 80 and over , Antibodies, Bacterial/blood , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Gram-Positive Bacterial Infections/blood , Humans , Male , Middle Aged , Predictive Value of Tests , Propionibacterium acnes/isolation & purification , Prostatic Hyperplasia/blood , Prostatic Hyperplasia/microbiology , Prostatic Neoplasms/blood , Prostatic Neoplasms/microbiology , Regression Analysis
5.
BJU Int ; 98(2): 388-92, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16879683

ABSTRACT

OBJECTIVE: To assess whether colonization of the male urinary tract with Propionibacterium acnes, in particular types IB and II (which are associated with inflammation in radical prostatectomy specimens and might be involved in the development of prostate cancer), is associated with prostate disease, and thus to develop a urine test to detect men at risk of prostate disease. PATIENTS, SUBJECTS AND METHODS: We developed the first polymerase chain reaction (PCR)-based technique for identifying P. acnes types IA, IB and II, and used this in combination with selective culture medium to compare the prevalence of these subtypes in the urinary tract of adolescent males, healthy adult men and patients with confirmed prostate pathology. RESULTS: P. acnes types IB and II were no more prevalent in the urinary tract of patients with prostate pathology than in normal control men. However, the prevalence of types IB and II appeared to be higher in adult men (at 11 of 15 and six of 15, respectively) than in adolescents (two of six and one of six), suggesting an age-related increase. Comparison of urinary tract and facial skin P. acnes from three subjects showed that type IA was more often predominant on facial skin, whereas types IB or II were more often predominant in the urinary tract. CONCLUSIONS: A urine test might not be useful for detecting men with prostatic P. acnes infection and thus at greater risk of associated prostate disease. However, this work validated our technique for detecting and identifying the three P. acnes subtypes, and identified some interesting trends worth further investigation.


Subject(s)
Gram-Positive Bacterial Infections/diagnosis , Polymerase Chain Reaction/methods , Propionibacterium acnes/isolation & purification , Prostatic Diseases/diagnosis , Urinary Tract/microbiology , Adolescent , Adult , Bacterial Typing Techniques/methods , Female , Humans , Male , Middle Aged , Propionibacterium acnes/classification , Prostatic Diseases/microbiology , Urinalysis/methods
6.
Future Oncol ; 2(2): 225-32, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16563091

ABSTRACT

Incidental foci of prostate cancer are found at autopsy in 30% of men in their third decade, and by their eighth decade more than 75% have histological evidence of cancer. This unprecedented cancer prevalence points to a ubiquitous causative agent or perhaps an interaction between multiple common carcinogenic cofactors. We propose that one of these carcinogens is Propionibacterium acnes. Several characteristics of prostate cancer suggest the involvement of an infectious agent and we provide evidence that P. acnes is an excellent candidate. We have cultured P. acnes from a substantial proportion of prostate glands containing cancer and shown a significant positive association with prostatic inflammation. P. acnes is well suited to cause persistent, low-grade infection involving a marked inflammatory response and the P. acnes subtypes most frequently associated with prostate cancer become highly prevalent in the urinary tract of males following puberty.


Subject(s)
Gram-Positive Bacterial Infections/microbiology , Propionibacterium acnes/pathogenicity , Prostatic Neoplasms/microbiology , Humans , Male
7.
J Urol ; 173(6): 1969-74, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15879794

ABSTRACT

PURPOSE: Inflammation is commonly observed in the prostate gland and has been implicated in the development of prostate cancer. The etiology of prostatic inflammation is unknown. However, the involvement of a carcinogenic infectious agent has been suggested. MATERIALS AND METHODS: Prostatic tissue from 34 consecutive patients with prostate cancer was cultured to detect the presence of bacterial agents. Prostatic inflammation was assessed by histological examination of wholemount tissue sections. RESULTS: The predominant microorganism detected was Propionibacterium acnes, found in 35% of prostate samples. A significantly higher degree of prostatic inflammation was observed in cases culture positive for P. acnes (p =0.007). P. acnes was separated into 3 groups based on cell surface properties, phenotype and genetic grouping. All skin control isolates were classified as group 1 whereas most prostatic isolates were classified as groups 2 and 3. CONCLUSIONS: P. acnes has been isolated from prostatic tissues in men who underwent radical prostatectomy for localized cancer and has been shown to be positively associated with prostatic inflammation. This inflammation may then be linked to the evolution of carcinoma. Furthermore, organisms infecting these patients with prostate cancer differ genetically and phenotypically from the commonly identified cutaneous P. acnes isolates, suggesting that specific subtypes may be involved in development of prostatic inflammation.


Subject(s)
Gram-Positive Bacterial Infections/pathology , Propionibacterium acnes/pathogenicity , Prostatic Neoplasms/pathology , Prostatitis/pathology , Bacteriological Techniques , Carboxyl and Carbamoyl Transferases/analysis , Cell Transformation, Neoplastic/pathology , Gram-Positive Bacterial Infections/microbiology , Humans , Male , Polymerase Chain Reaction , Prostate/microbiology , Prostate/pathology , Prostatectomy , Prostatic Neoplasms/genetics , Prostatic Neoplasms/microbiology , Prostatic Neoplasms/surgery , Prostatitis/microbiology , Sequence Analysis, DNA , Skin/microbiology , Skin/pathology , Virulence/genetics
8.
Lab Invest ; 82(2): 167-82, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11850530

ABSTRACT

Overexpression of vascular endothelial growth factor (VEGF) has been strongly implicated in the development of choroidal neovascularization (CNV) in patients with age-related macular degeneration. In this study, a phosphorothioate oligonucleotide (PS-oligo) targeting both human and rat VEGF(165) genes upstream of the translation initiation code, named DS135 in this study, was evaluated for its uptake dynamics and retinal tolerance after intravitreal (IV) and subretinal (SR) injections in the rhesus monkey. Intravitreal and SR injections of a fluorescent-labeled DS135 (FL-DS135) resulted in both dose- and time-dependent uptake and persistence, and FL-DS135 remained detectable in the retina for at least 3 weeks after injection. Ophthalmic examination showed transient vitreous haze after IV delivery of a high dose but not with a low dose of FL-DS135. Histologic examination showed no evidence of retinal degeneration with respect to IV delivery. After SR delivery, however, dose-related cellular infiltration, transient residual fluid, and slight distortion of the neuroretina were observed. The biologic efficacy of DS135 was further assessed in a laser-induced CNV model, and development of CNV was determined by fluorescein angiography and histologic examination. Incomplete inhibition of CNV formation was observed after IV and SR injection of DS135, but no statistically significant difference was achieved when compared with dose-matched control of PS-oligo. Analysis of fluorescein angiogram and histologic examination showed less than 30% incidence of CNV development in this monkey model. Our study demonstrated that PS-oligos can be successfully introduced into the retina, although with potential limitations, after SR delivery. DS135, a PS-oligo targeting the VEGF gene upstream of the translation initiation code, partially inhibited CNV formation. An improved CNV model is necessary for further confirmation of the full therapeutic potency of DS135 before clinical application.


Subject(s)
Organophosphorus Compounds/chemistry , Retina/drug effects , Thionucleotides/pharmacology , Animals , Base Sequence , Choroidal Neovascularization/prevention & control , DNA Primers , Drug Evaluation, Preclinical , Laser Coagulation , Macaca mulatta , Thionucleotides/chemistry , Thionucleotides/pharmacokinetics
9.
Biomaterials ; 23(2): 321-42, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11761152

ABSTRACT

Developed over the past two decades, the antisense strategy has become a technology of recognised therapeutic potential, and many of the problems raised earlier in its application have been solved to varying extents. However, the adequate delivery of antisense oligodeoxynucleotides to individual cells remains an important and inordinately difficult challenge. Synthetic polymers appeared on this scene in the middle 1980s, and there is a surprisingly large variety used or proposed so far as agents for delivery of oligodeoxynucleotides. After discussing the principles of antisense strategy, certain aspects of the ingestion of macromolecules by cells, and the present situation of delivery procedures, this article analyses in detail the attempts to use synthetic polymers as carrier matrices and or cell membrane permeabilisation agents for delivery of antisense oligodeoxynucleotides. Structural aspects of various polymers, as well as the results, promises and limitations of their use are critically evaluated.


Subject(s)
Drug Carriers , Oligonucleotides, Antisense/administration & dosage , Polymers , Animals
SELECTION OF CITATIONS
SEARCH DETAIL
...